Steps in the evaluation process

Notification of receipt of application - These notices provide advice that a DIR licence application has been received by the OGTR and that a RARMP is in preparation.

Public calls for comment - The Regulator has invited the public to provide comment on a RARMP regarding the identified risk(s) to human health and the environment and the proposed management measures.

Call for comment closed - Comments on these RARMPs have closed, the Regulator is considering submissions and a decision on the licence is imminent.

Summary of the evaluation process for DIR licence applications flow chart

For more information about DIR applications, please contact the OGTR. DIR applications are available on request (excluding any information that the Regulator has declared to be, or is under consideration as, Confidential Commercial Information) to anyone that requests a copy (section 54 of the Act). A summary of application and, once prepared, the RARMP for each application is available on this website.
Represents the status of licence applications and includes links to the relevant documents
DIR Licence Application Number Title of Project Notification of receipt of application Public calls for comment on RARMP open Call for comment closed (under consideration by the Regulator) Is application being assessed as ‘limited and controlled’?
DIR 136Limited and controlled release of cotton genetically modified for enhanced fibre quality26 Mar 2015Yes
DIR 135Limited and controlled release of sugarcane genetically modified for enhanced sugar content – The University of Queensland06 Feb 2015Yes
DIR 134Commercial import and distribution of genetically modified carnations with altered flower colour - International Flower Developments Pty Ltd22 Jan 2015No
DIR 133Limited and controlled release of cotton genetically modified for insect resistance and herbicide tolerance - Bayer CropScience Pty Ltd21 Nov 201425 Feb 2015Yes
DIR 132Commercial release of a tumour-selective genetically modified virus for cancer therapy (Amgen Australia Pty Ltd)27 Oct 2014No

View the list of DIRs.